PR
Therapeutic Areas
Allogenetics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Organ Engineering Program(s) | Prevention of Organ Transplant Rejection | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Organ Engineering Program(s) | Prevention of Organ Transplant Rejection | Preclinical |